Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation

References

• Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
   PubMed Web of Science ®Google Scholar
• Atallah A, Lecarpentier E, Goffinet F, et al. Aspirin for prevention of preeclampsia. Drugs. 2017;77(17):1819–1831.
   PubMed Web of Science ®Google Scholar
• Shanmugalingam R, Hennessy A, Makris A. Aspirin in the prevention of preeclampsia: the conundrum of how, who and when. J Hum Hypertens. 2019;33(1):1–9.
   PubMed Web of Science ®Google Scholar
• Xu T T, Zhou F, Deng C y, et al. Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis. J Clin Hypertens. 2015;17(7):567–573.
   PubMed Web of Science ®Google Scholar
• Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323–e333.
   PubMed Web of Science ®Google Scholar
• Hakim J, Senterman MK, Hakim AM. Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system. Int J Pediatr. 2013;2013:953150.
   PubMedGoogle Scholar
• Sidorov EV, Feng W, Caplan LR. Stroke in pregnant and postpartum women. Expert Rev Cardiovasc Ther. 2011;9(9):1235–1247.
   PubMedGoogle Scholar
• Brichant G, Dewandre PY, Foidart JM, et al. Management of severe preeclampsia. Acta Clin Belg. 2010;65(3):163–169.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart D, Knight M,et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Syst Rev. 2003;4:CD004659.
   Google Scholar
• Duley L, Henderson‐Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre‐eclampsia and its complications. Cochrane Database Syst Rev. Epub ahead of print 2007;2:CD004659.
   Google Scholar
• Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre‐eclampsia and its complications (review). Cochrane Database Syst Rev. 2019;10:1–286.
   Google Scholar
• World Health Organization. WHO Recommendations for Prevention and treatment of pre-eclampsia and eclampsia, http://apps.who.int/iris/bitstream/handle/10665/44703/9789241548335_eng.pdf;jsessionid=66F285A066AB79C578D943181613B2B5?sequence=1. 2011. Accessed 16 August 2021).
   Google Scholar
• LeFevre ML, Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia:U.S. Preventive services task force recommendation statement. Ann Intern Med. 2014;161(11):819–826.
   PubMed Web of Science ®Google Scholar
• Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–441.
   PubMedGoogle Scholar
• NICE Guideline. Hypertension in pregnancy: diagnosis and management. London: National Institution for Health and Care Excellence, 2019.
   Google Scholar
• Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55(5):e1-29–29.
   PubMed Web of Science ®Google Scholar
• ACOG Committee. ACOG Committee Opinion: low-dose aspirin use during pregnancy, https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/07/low-dose-aspirin-use-during-pregnancy.
   Google Scholar
• ACOG Committee Opinion No 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44–e52.
   PubMed Web of Science ®Google Scholar
• Nansseu JRN, Noubiap JJN. Aspirin for primary prevention of cardiovascular disease. Thrombosis J. Epub ahead of print 4 December 2015;13(1):1–10.
   PubMedGoogle Scholar
• Wen SW, White RR, Rybak N, et al. Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial. BMJ. 2018;362:k3478.
   PubMedGoogle Scholar
• Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1998;338(11):701–705.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Corsi DJ, Gaudet LM, El-Chaar D, et al. Effect of high-dose folic acid supplementation on the prevention of preeclampsia in twin pregnancy. J Matern-FetalNeonatal Med. 2020;0:1–6.
   Google Scholar
• Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285–293.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LCY, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50(4):492–495.
   PubMed Web of Science ®Google Scholar
• Hibbs AM, Black D, Palermo L, et al. Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr. 2010;156(2):202–208.
   PubMed Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
   PubMed Web of Science ®Google Scholar
• Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 2002;109(10):1321–1326.
   PubMed Web of Science ®Google Scholar
• Ertugrul DT, Tutal E, Yildiz M, et al. Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(6):2897–2901.
   PubMed Web of Science ®Google Scholar
• Rose EG, Murphy MSQ, Erwin E, et al. Gestational folate and folic acid intake among women in Canada at higher risk of pre-eclampsia. J Nutri. Epub ahead of print 13 April 2021;151(7):1976–1982.
   PubMed Web of Science ®Google Scholar
• Rossi AC, Mullin PM. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2011;158(1):9–16.
   PubMed Web of Science ®Google Scholar
• Wertaschnigg D, Wang R, Reddy M, et al. Treatment of severe hypertension during pregnancy: we still do not know what the best option is. Hypertens Pregnancy. 2020;39(1):25–32.
   PubMed Web of Science ®Google Scholar
• Lin L, Huai J, Li B, et al. A randomized controlled trial of low-dose aspirin for the prevention of pre-eclampsia in women at high-risk in China (the APPEC study). Am J Obstet Gynecol. 2022;226(2):251–e1.
   Google Scholar
• Chaemsaithong P, Cuenca-Gomez D, Plana MN, et al. Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia? Am J Obstet Gynecol. 2020;222(5):437–450.
   PubMed Web of Science ®Google Scholar
• Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int. 2012;2012:796590.
   PubMedGoogle Scholar
• Nielsen MJ, Nørgaard M, Holland-Fisher P, et al. Self-reported antenatal adherence to medical treatment among pregnant women with crohn’s disease. Alimentary Pharmacology & Therapeutics. 2010;32(1):49–58.
   PubMed Web of Science ®Google Scholar
• Julsgaard M, Nørgaard M, Hvas CL, et al. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis. 2011;17(7):1573–1580.
   PubMed Web of Science ®Google Scholar
• Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–214.
   PubMed Web of Science ®Google Scholar